News | December 01, 2023
New global survey finds widespread misunderstandings about shingles despite its lifetime prevalence
A new GSK survey shows a large number of adults do not understand how shingles may be triggered
A new GSK survey shows a large number of adults do not understand how shingles may be triggered
Accelerating FDA submission and confirming potential to become first approved biologic for this serious disease
Establishes connected software and data foundation for the future with next-generation life sciences CRM and harmonized customer data
First-ever brain chemistry database will allow clinicians to quickly infer brain biomarker data to support the diagnostic process in conditions such as Alzheimer's Disease
The newly established business will be looking for high-quality, mid- to late-stage assets, clinically focused on the United States market
Evinova will operate as a separate health-tech business within AstraZeneca
Gene therapy AB-1005 being developed to locally increase glial cell line-derived neurotrophic factor (GDNF) levels
Nerivio is a prescription-based non-invasive device intended for acute and prophylactic (preventive) treatment of migrain
XTANDI becomes the first and only androgen receptor signaling inhibitor approved for use with or without a GnRH analog therapy in nonmetastatic castration-sensitive prostate cancer
Dr. Reddy’s maintains that the allegations against it lack merit and will vigorously defend the litigation
Subscribe To Our Newsletter & Stay Updated
